TITLE

Assessment of intra-observer variability in measurement of high-grade brain tumors

AUTHOR(S)
Provenzale, James; Mancini, Michael
PUB. DATE
July 2012
SOURCE
Journal of Neuro-Oncology;Jul2012, Vol. 108 Issue 3, p477
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A 25% increase in bidimensional products (BPs) of tumor diameter has been used as a criterion for brain tumor progression. We studied intra-observer variability in measurements of BPs. Ten patients with contrast-enhancing glioblastoma multiforme underwent baseline and follow-up MR imaging. Seven observers measured BPs in various planes. Differences in BPs between scans were expressed as a percentage of baseline. This calculation was performed for both readings of the baseline and follow-up scans. Differences between change from baseline to follow-up on each reading (termed D values) were calculated for each reader (total of 196 D values). Median D value in each plane was calculated for each reader. Range of D values was 12.36-33.64% in axial plane (average 10.63%), 12.18-38.62% in coronal plane (average 26.84%) and 15.12-35.48% in sagittal plane (average 26.11%). Across all planes, 88 (45%) D values were >25%. When all imaging planes for any single observation were combined, in 76% of cases, at least one D value of >25% was seen. Based on the high degree of intra-observer variability, tumor measurements producing an increase in BP of >25% can routinely be obtained solely by chance.
ACCESSION #
76350890

 

Related Articles

  • Procarbazine, carmustine, and vincristine (PBV) for chemotherapy pre-treated patients with recurrent glioblastoma: a single-institution analysis. Kuhnhenn, Jan; Kowalski, Thomas; Steenken, Sabine; Ostermann, Kathrin; Schlegel, Uwe // Journal of Neuro-Oncology;Sep2012, Vol. 109 Issue 2, p433 

    In newly diagnosed glioblastoma multiforme, surgery, combined radio and chemotherapy, and adjuvant chemotherapy with temozolomide is the standard of care. Therapy for recurrent glioblastoma is less well established and comprises re-operation, re-irradiation, chemotherapy, targeted therapy,...

  • Effects of slice thickness and head rotation when measuring glioma sizes on MRI: in support of volume segmentation versus two largest diameters methods. Schmitt, Pierre; Mandonnet, Emmanuel; Perdreau, Adrien; Angelini, Elsa // Journal of Neuro-Oncology;Apr2013, Vol. 112 Issue 2, p165 

    This paper presents a study of the effects of scanning parameters variability when assessing glioma sizes on MRI. A database of lesions of various shapes and sizes, segmented on 3D-SPGR MRI images, was acquired on 65 patients with low-grade glioma. Simulations of large slice thickness and...

  • Analysis of the Effect of different types of lumbar disc herniation treated by medical ozone. Yang yang Li Yan-hao He Xiao-feng // International Journal of Ozone Therapy;Apr2012, Vol. 11 Issue 1, p52 

    Objective: To compare the effects of ruptured lumbar disc protrusion and unruptured lumbar disc protrusion treated by ozone, to access its different mechanisms and provide evidences for clinical application. Methods:To collect 1000 patients diagnosised wilh Lumbar intervertebral disc lesions...

  • Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities. Diem Kieu Thi Tran; Jensen, Randy L. // Surgical Neurology International;2013, Vol. 4 Issue Supp 3, pS129 

    Background: Glioblastoma multiforme (GBM) has a dismal prognosis despite aggressive therapy. Initial diagnosis and measurement of response to treatment is usually determined by measurement of gadolinium-enhanced tumor volume with magnetic resonance imaging (MRI). Unfortunately, many GBM...

  • Hypofractionated stereotactic reirradiation for recurrent glioblastoma. Yazici, Gozde; Cengiz, Mustafa; Ozyigit, Gokhan; Eren, Gulnihan; Yildiz, Ferah; Akyol, Fadil; Gurkaynak, Murat; Zorlu, Faruk // Journal of Neuro-Oncology;Oct2014, Vol. 120 Issue 1, p117 

    Treatment choices for recurrent glioblastoma patients are sparse and the results are not satisfactory. In this retrospective analysis, we evaluated the results of re-irradiation of locally recurrent glioblastoma patients with an image-guided, fractionated, frameless stereotactic radiotherapy...

  • Changes in functional MRI signals after 3D based radiotherapy of glioblastoma multiforme. Kovács, Árpád; Emri, Miklós; Opposits, Gábor; Pisák, Tamás; Vandulek, Csaba; Glavák, Csaba; Szalai, Zoltán; Biró, Gergely; Bajzik, Gábor; Repa, Imre // Journal of Neuro-Oncology;Oct2015, Vol. 125 Issue 1, p157 

    The purpose of our study was to examine the potential effects of conventional 3D based radiotherapy on functional MRI activation areas following the treatment of glioblastoma multiforme. Seventeen patients with a histologically proven glioblastoma multiforme were enrolled in this study. A...

  • Pre- and post-contrast three-dimensional double inversion-recovery MRI in human glioblastoma. Harris, Robert; Cloughesy, Timothy; Pope, Whitney; Godinez, Sergio; Natsuaki, Yutaka; Nghiemphu, Phioanh; Meyer, Heiko; Paul, Dominik; Behbahanian, Yalda; Lai, Albert; Ellingson, Benjamin // Journal of Neuro-Oncology;Apr2013, Vol. 112 Issue 2, p257 

    Fluid attenuated inversion recovery (FLAIR) MRI sequences have become an indispensible tool for defining the malignant boundary in patients with brain tumors by nulling the signal contribution from cerebrospinal fluid allowing both regions of edema and regions of non-enhancing, infiltrating...

  • Monitoring Radiographic Brain Tumor Progression. Mehta, Ankit I.; Kanaly, Charles W.; Friedman, Allan H.; Bigner, Darell D.; Sampson, John H. // Toxins;Mar2011, Vol. 3 Issue 3, p191 

    Determining radiographic progression in primary malignant brain tumors has posed a significant challenge to the neuroncology community. Glioblastoma multiforme (GBM, WHO Grade IV) through its inherent heterogeneous enhancement, growth patterns, and irregular nature has been difficult to assess...

  • Hybrid PET/MR imaging in two sarcoma patients - clinical benefits and implications for future trials. Partovi, Sasan; Kohan, Andres A.; Zipp, Lisa; Faulhaber, Peter; Kosmas, Christos; Ros, Pablo R.; Robbin, Mark R. // International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 3, p640 

    PET/MRI is an evolving hybrid imaging modality which combines the inherent strengths of MRIs soft-tissue and contrast resolution and PETs functional metabolic capabilities. Bone and soft-tissue sarcoma are a relatively rare tumor entity, relying on MRI for local staging and often on PET/CT for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics